3. 2015/03/21 REQUIRE 19: Lancet特集号の理解 / 研究の価値を⾼め無駄を減らす 3
しかし、じじょうがかわった!
Jan 14, 2015
Institute of Medicine (IOM) of the National Academies
Sharing Clinical Trial Data
Maximizing Benefits, Minimizing Risk
Committee on Strategies for
Responsible Sharing of Clinical Trial Data
Board on Health Science Policy
4. Prefaceより
(前略)
The issue is no longer whether to share clinical
trial data, but what specific data to share, at
what time, and under what conditions.
(後略)
2015/03/21 REQUIRE 19: Lancet特集号の理解 / 研究の価値を⾼め無駄を減らす 4
IOM’s Report
30. Individual
Participant Data
Individual
Participant Data
Metadata
2015/03/21 REQUIRE 19: Lancet特集号の理解 / 研究の価値を⾼め無駄を減らす 30
パッケージ化!
Trial Design
& Registration
Trial Design
& Registration
Study Completion
or Termination
Study Completion
or Termination
Participant
Enrollment
Participant
Enrollment
PublicationPublication
NoNo
Regulatory
Application?
Regulatory
Application?
YesYes
At Trial Registration
Data Sharing Plan
Registration Elements
At Trial Registration
Data Sharing Plan
Registration Elements
12 months after study
completion
Summary-level results
Lay Summaries
12 months after study
completion
Summary-level results
Lay Summaries
6 months after
publication
Post-Publication data
Package
6 months after
publication
Post-Publication data
Package
18 months after study
completion
Full Data Packages
18 months after study
completion
Full Data Packages
18 monts after product
abandonment OR 30 days
after regulatory approval
Post-Regulatory data
package
18 monts after product
abandonment OR 30 days
after regulatory approval
Post-Regulatory data
package
IOM’s report (2015) より作成